-
1
-
-
38349192580
-
New drugs for the treatment of diabetes mellitus: Part I: Thiazolidinediones and their evolving cardiovascular implications
-
McGuire DK, Inzucchi SE. New drugs for the treatment of diabetes mellitus: part I: thiazolidinediones and their evolving cardiovascular implications. Circulation 2008;117:440-449.
-
(2008)
Circulation
, vol.117
, pp. 440-449
-
-
McGuire, D.K.1
Inzucchi, S.E.2
-
2
-
-
41049110803
-
New drugs for the treatment of diabetes: Part II: Incretin-based therapy and beyond
-
Inzucchi SE, McGuire DK. New drugs for the treatment of diabetes: part II: incretin-based therapy and beyond. Circulation 2008;117:574-584.
-
(2008)
Circulation
, vol.117
, pp. 574-584
-
-
Inzucchi, S.E.1
McGuire, D.K.2
-
3
-
-
67650233277
-
Cardiovascular disease and type 2 diabetes mellitus: Regulating glucose and regulating drugs
-
Gore MO, McGuire DK. Cardiovascular disease and type 2 diabetes mellitus: regulating glucose and regulating drugs. Curr Cardiol Rep 2009;11:258-263.
-
(2009)
Curr Cardiol Rep
, vol.11
, pp. 258-263
-
-
Gore, M.O.1
McGuire, D.K.2
-
4
-
-
79958197888
-
Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study
-
First published on 6 April 2011. doi: 10.1093/eurheartj/ehr077
-
Schramm TK, Gislason GH, Vaag A, Rasmussen JN, Folke F, Hansen ML, Fosbøl EL, Køber L, Norgaard ML, Madsen M, Hansen PR, Torp-Pedersen C. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study. Eur Heart J 2011;32:1900-1908. First published on 6 April 2011. doi: 10.1093/eurheartj/ ehr077.
-
(2011)
Eur Heart J
, vol.32
, pp. 1900-1908
-
-
Schramm, T.K.1
Gislason, G.H.2
Vaag, A.3
Rasmussen, J.N.4
Folke, F.5
Hansen, M.L.6
Fosbøl, E.L.7
Køber, L.8
Norgaard, M.L.9
Madsen, M.10
Hansen, P.R.11
Torp-Pedersen, C.12
-
5
-
-
0032511566
-
Effect of intensive bloodglucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
-
UK Prospective Diabetes Study (UKPDS) Group
-
UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive bloodglucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-865.
-
(1998)
Lancet
, vol.352
, pp. 854-865
-
-
-
6
-
-
0015153101
-
Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results
-
Goldner MG, Knatterud GL, Prout TE. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results. JAMA 1971;218:1400-1410.
-
(1971)
JAMA
, vol.218
, pp. 1400-1410
-
-
Goldner, M.G.1
Knatterud, G.L.2
Prout, T.E.3
-
7
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
UK Prospective Diabetes Study (UKPDS) Group
-
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: 837-853.
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
8
-
-
45149133036
-
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
-
DOI 10.1056/NEJMoa0802987
-
Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B; the ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572. (Pubitemid 351831357)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.24
, pp. 2560-2572
-
-
Patel, A.1
MacMahon, S.2
Chalmers, J.3
Neal, B.4
Billot, L.5
Woodward, M.6
Marre, M.7
Cooper, M.8
Glasziou, P.9
Grobbee, D.10
Hamet, P.11
Harrap, S.12
Heller, S.13
Liu, L.14
Mancia, G.15
Mogensen, C.E.16
Pan, C.17
Poulter, N.18
Rodgers, A.19
Williams, B.20
Bompoint, S.21
De Galan, B.E.22
Joshi, R.23
Travert, F.24
more..
-
9
-
-
60449089649
-
Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
-
Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203.
-
(2009)
Diabetes Care
, vol.32
, pp. 193-203
-
-
Nathan, D.M.1
Buse, J.B.2
Davidson, M.B.3
Ferrannini, E.4
Holman, R.R.5
Sherwin, R.6
Zinman, B.7
-
10
-
-
0036894342
-
Sulfonylurea stimulation of insulin secretion
-
Proks P, Reimann F, Green N, Gribble F, Ashcroft F. Sulfonylurea stimulation of insulin secretion. Diabetes 2002;51 Suppl 3:S368-S376. (Pubitemid 35403418)
-
(2002)
Diabetes
, vol.51
, Issue.SUPPL. 3
-
-
Proks, P.1
Reimann, F.2
Green, N.3
Gribble, F.4
Ashcroft, F.5
-
11
-
-
9444284451
-
+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium
-
DOI 10.2337/diabetes.53.suppl-3.S156
-
Quast U, Stephan D, Bieger S, Russ U. The impact of ATP-sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium. Diabetes 2004;53 Suppl 3:S156-S164. (Pubitemid 39564538)
-
(2004)
Diabetes
, vol.53
, Issue.SUPPL. 3
-
-
Quast, U.1
Stephan, D.2
Bieger, S.3
Russ, U.4
-
12
-
-
27844440474
-
Realizing the clinical potential of ischemic preconditioning and postconditioning
-
DOI 10.1038/ncpcardio0346, PII N0346
-
Yellon DM, Hausenloy DJ. Realizing the clinical potential of ischemic preconditioning and postconditioning. Nat Clin Pract Cardiovasc Med 2005;2:568-575. (Pubitemid 41655660)
-
(2005)
Nature Clinical Practice Cardiovascular Medicine
, vol.2
, Issue.11
, pp. 568-575
-
-
Yellon, D.M.1
Hausenloy, D.J.2
-
13
-
-
10744231601
-
Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes
-
DOI 10.1016/j.ahj.2003.07.024
-
McGuire DK, Newby LK, Bhapkar MV, Moliterno DJ, Hochman JS, Klein WW, Weaver WD, Pfisterer M, Corbalán R, Dellborg M, Granger CB, Van De Werf F, Topol EJ, Califf RM; SYMPHONY and 2nd SYMPHONY Investigators. Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes. Am Heart J 2004;147:246-252. (Pubitemid 38176824)
-
(2004)
American Heart Journal
, vol.147
, Issue.2
, pp. 246-252
-
-
McGuire, D.K.1
Newby, L.K.2
Bhapkar, M.V.3
Moliterno, D.J.4
Hochman, J.S.5
Klein, W.W.6
Weaver, W.D.7
Pfisterer, M.8
Corbalan, R.9
Dellborg, M.10
Granger, C.B.11
Van De Werf, F.V.12
Topol, E.J.13
Califf, R.M.14
-
14
-
-
0031451561
-
Possible risk of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus and coronary artery disease [1]
-
DOI 10.1007/s001250050855
-
Muhlhauser I, Sawicki PT, Berger M. Possible risk of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus and coronary artery disease. Diabetologia 1997;40:1492-1493. (Pubitemid 28004946)
-
(1997)
Diabetologia
, vol.40
, Issue.12
, pp. 1492-1493
-
-
Muhlhauser, I.1
Sawicki, P.T.2
Berger, M.3
-
15
-
-
45149131667
-
Effects of intensive glucose lowering in type 2 diabetes
-
DOI 10.1056/NEJMoa0802743
-
Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559. (Pubitemid 351831356)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.24
, pp. 2545-2559
-
-
Friedewald, W.T.1
Buse, J.B.2
Bigger, J.T.3
Byington, R.P.4
Cushman, W.C.5
Gerstein, H.C.6
Ginsberg, H.N.7
Goff Jr., D.C.8
Grimm Jr., R.H.9
Ismail-Beigi, F.10
Probstfield, J.L.11
Simons-Morton, D.G.12
-
16
-
-
77957742069
-
Severe hypoglycemia and risks of vascular events and death
-
ADVANCE Collaborative Group
-
Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, Woodward M, Ninomiya T, Neal B, MacMahon S, Grobbee DE, Kengne AP, Marre M, Heller S; ADVANCE Collaborative Group. Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010;363:1410-1418.
-
(2010)
N Engl J Med
, vol.363
, pp. 1410-1418
-
-
Zoungas, S.1
Patel, A.2
Chalmers, J.3
De Galan, B.E.4
Li, Q.5
Billot, L.6
Woodward, M.7
Ninomiya, T.8
Neal, B.9
MacMahon, S.10
Grobbee, D.E.11
Kengne, A.P.12
Marre, M.13
Heller, S.14
|